213 results on '"Kaufman, Ronald P."'
Search Results
2. Aquablation therapy in large prostates (80-150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3-year trial results.
3. WATER versus WATER II 5‐year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30–80‐cm3 and 80–150‐cm3 prostates.
4. Reply by Authors
5. Reply: Complications Following Transrectal and Transperineal Prostate Biopsy: Results of the ProBE-PC Randomized Clinical Trial
6. ENLIGHTED phase 3 study: Efficacy and safety of padeliporfin vascular targeted photodynamic therapy (VTP) for treatment of low-grade upper tract urothelial cancer (LG UTUC).
7. PD50-05 PATIENT-LEVEL DATA ON COMPLICATIONS FOLLOWING PROSTATE BIOPSY: RESULTS FROM THE PROBE-PC RANDOMIZED CLINICAL TRIAL
8. Outreach and Influence of Surgical Societies’ Recommendations on Minimally Invasive Surgery During the COVID-19 Pandemic—An Anonymized International Urologic Expert Inquiry
9. Use of Transesophageal Echocardiogram and Interdisciplinary Approach to Intraoperative Management of Renal Cell Carcinoma With Inferior Vena Cava Invasion
10. Retreatment rates and postprocedural complications are higher than expected after BPH surgeries: a US healthcare claims and utilization study
11. Evaluating the Safety and Efficacy of a Novel Polysaccharide Hemostatic System During Surgery: A Multicenter Multispecialty Prospective Randomized Controlled Trial
12. Correction: Retreatment rates and postprocedural complications are higher than expected after BPH surgeries: a US healthcare claims and utilization study
13. WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation® vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia
14. Enhanced Recovery after Partial and Radical Nephrectomy Reduces Length of Stay, Opioid Use and Cost
15. Implementation and Assessment of No Opioid Prescription Strategy at Discharge After Major Urologic Cancer Surgery
16. Evaluating the Safety and Efficacy of a Novel Polysaccharide Hemostatic System for Multidisciplinary Application: A Multicenter Prospective Randomized Controlled Trial
17. MP09-08 PATIENT-REPORTED PREFERENCE BETWEEN TRANSRECTAL AND TRANSPERINEAL PROSTATE BIOPSY
18. NEGATIVE PREDICTIVE VALUE OF A NEGATIVE MULTI-PARAMETRIC MRI OF PROSTATE: MP53-02
19. Tissue-marking scheme for a cost-effective extended prostate biopsy protocol
20. Aquablation therapy in large prostates (80–150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3‐year trial results
21. PD18-06 AQUABLATION FOR BENIGN PROSTATIC HYPERPLASIA IN LARGE PROSTATES (80-150CC): 3-YEAR RESULTS
22. PSA-related markers in the detection of prostate cancer and high-grade disease in the contemporary era with extended biopsy
23. Loss of claudins-1 and -7 and expression of claudins-3 and -4 correlate with prognostic variables in prostatic adenocarcinomas
24. Rationale and protocol for randomized study of transrectal and transperineal prostate biopsy efficacy and complications (ProBE-PC study)
25. Survivin and Bcl-2 expression in prostatic Adenocarcinomas
26. Role of prostate biopsy schemes in accurate prediction of Gleason scores
27. Re: Cost-Effectiveness of Percutaneous Tibial Nerve Stimulation Versus Extended Release Tolterodine for Overactive Bladder
28. Aquablation for Benign Prostatic Hyperplasia in Large Prostates (80-150 cc): 1-Year Results
29. Reply by Authors
30. Expression of Small Noncoding RNAs in Urinary Exosomes Classifies Prostate Cancer into Indolent and Aggressive Disease
31. Smad4 protein expression correlates with grade, stage, and DNA ploidy in prostatic adenocarcinomas
32. PROGNOSTIC SIGNIFICANCE OF HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA AND ATYPICAL SMALL ACINAR PROLIFERATION IN THE CONTEMPORARY ERA
33. PRENATAL ULTRASOUND HAS LED TO EARLIER DETECTION AND REPAIR OF URETEROPELVIC JUNCTION OBSTRUCTION
34. Decreased expression of catenins (alpha and beta), p120 CTN, and E-cadherin cell adhesion proteins and E-cadherin gene promoter methylation in prostatic adenocarcinomas
35. MP62-06 A US HEALTHCARE CLAIMS ANALYSIS REVEALS POST-SURGERY MEDICATION USE THROUGH 5 YEARS IS SIMILAR BETWEEN PUL, TURP AND GREENLIGHT.
36. PD20-02 EFFICACY AND SAFETY OF PADELIPORFIN VASCULAR TARGETED PHOTODYNAMIC THERAPY (VTP) FOR TREATMENT OF LOW-GRADE UPPER TRACT UROTHELIAL CANCER (LG UTUC): PHASE 3 PRELIMINARY RESULTS.
37. MP20-01 WATER vs WATER II 3-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80 cc and 80-150 cc Prostates.
38. Two-Year Outcomes After Aquablation Compared to TURP: Efficacy and Ejaculatory Improvements Sustained
39. Aquablation for benign prostatic hyperplasia in large prostates (80-150 mL): 6-month results from the WATER II trial
40. The prognostic significance of proliferation-associated nucleolar protein p120 expression in prostate adenocarcinoma: a comparison with cyclins A and B1, Ki-67, proliferating cell nuclear antigen, and p34(super)cdc2
41. VOIDING FUNCTION IN PATIENTS UNDERGOING PROSTATIC CRYOABLATION--A PREOPERATIVE URODYNAMIC ANALYSIS
42. NEOADJUVANT ANDROGEN DEPRIVATION THERAPY (ADT) PRIOR TO RADICAL PROSTATECTOMY (RP) DECREASES POSITIVE MARGINS FOR cT1C PROSTATE CANCER
43. CLINICAL CORRELATION OF DNA PLOIDY AND CELLULAR BIOMARKERS OF PREOPERATIVE PROSTATE NEEDLE BIOPSY SPECIMENS TO PREDICT PROSTATE CANCER PROGRESSION
44. NEUTROPHIL CD18 INTEGRIN EXPRESSION AND MATRIX FIBRONECTIN DISRUPTION: MECHANISMS FOR NEUTROPHIL MEDIATED INTRARENAL VASCULAR INJURY
45. The prognostic significance of p34(super cdc2) and cyclin D1 protein expression in prostate adenocarcinoma
46. Prognostic significance of HER-2/neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma
47. Symptom relief and anejaculation after aquablation or transurethral resection of the prostate: subgroup analysis from a blinded randomized trial
48. WATER II (80-150 mL) procedural outcomes
49. Novel platform for monitoring bladder cancer recurrence using expression analysis of small non-coding RNAs.
50. Validation of a new diagnostic platform for prostate cancer using expression profiling of small non-coding RNAs.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.